What does CUSIP 37890U958 represent in this 13F holders report?

CUSIP 37890U958 is the security identifier for 37890U958 - GLOBAL BLOOD THERAPEUTICS IN - PUT used to aggregate holder disclosures.

How many institutions held 37890U958 - GLOBAL BLOOD THERAPEUTICS IN - PUT in Q2 2020?

No institutional holders were reported for 37890U958 - GLOBAL BLOOD THERAPEUTICS IN - PUT in Q2 2020; review adjacent reporting periods for trend context.

GLOBAL BLOOD THERAPEUTICS IN - PUT

CUSIP: 37890U958

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / PUT
Price per share: $6000.00
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 37890U958?
CUSIP 37890U958 identifies 37890U958 - GLOBAL BLOOD THERAPEUTICS IN - PUT in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 37890U958:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

GLOBAL BLOOD THERAPEUTICS IN - PUT

Q2 2020 13F Holders as of 30 Jun 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of GLOBAL BLOOD THERAPEUTICS IN - PUT as of Q2 2020.